A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Public ClinicalTrials.gov record NCT00885742. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Congenital deficiency of factor XIII (FXIII) is an extremely rare inherited disorder associated with potentially life-threatening bleeding. Factor XIII Concentrate is given to patients whose blood is lacking factor XIII. Factor XIII Concentrate works by assisting blood in the usual clotting process, thereby preventing bleeding. In this study, patients will be treated with FXIII Concentrate (Human) and followed closely to determine that they receive the dose that will best minimize the chance of bruising and bleeding.
Study identification
- NCT ID
- NCT00885742
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Apr 2011 (Actual)
- Completion
- Apr 2011 (Actual)
- Last update posted
- Jul 16, 2012
2009 – 2011
United States locations
- U.S. sites
- 22
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site | Dothan | Alabama | 36305 | — |
| Study Site | Oakland | California | 94610 | — |
| Study Site | Orange | California | 92868 | — |
| Study Site | San Francisco | California | 94115 | — |
| Study Site | Stockton | California | 95204 | — |
| Study Site | Hartford | Connecticut | 06106 | — |
| Study Site | Fort Meyers | Florida | 33908 | — |
| Study | Miami | Florida | 33136 | — |
| Study Site | Boise | Idaho | 83712 | — |
| Study Site | South Bend | Indiana | 46601 | — |
| Study Site | Boston | Massachusetts | 02115 | — |
| Study Site | Saint Paul | Minnesota | 55102 | — |
| Study Site | Kansas City | Missouri | 64108 | — |
| Study Site | Las Vegas | Nevada | 89015 | — |
| Study Site | Lebanon | New Hampshire | 03756 | — |
| Study Site | Newark | New Jersey | 07102 | — |
| Study Site | Albany | New York | 12208 | — |
| Study Site | New York | New York | 10021 | — |
| Study Site | Chapel Hill | North Carolina | 27599 | — |
| Study Site | Hershey | Pennsylvania | 17033 | — |
| Study Site | Dallas | Texas | 75390 | — |
| Study Site | Milwaukee | Wisconsin | 53233 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00885742, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2012 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00885742 live on ClinicalTrials.gov.